Support CBSD
Our mission is to improve health outcomes by accelerating appropriate, timely, and equitable patient access to biomedical products in ways that work for all stakeholders.
We welcome the opportunity to speak with you about philanthropic gifts and social impact investments to support our efforts at the Center for Biomedical System Design at Tufts Medical Center. Please contact Gigi Hirsch to learn more.
Highlights of our contributions to patient-centered healthcare innovation
BioCentury: The unsung public policy innovators paving the path to cures
How NEWDIGS, Duke-Margolis’ public policy innovation is enabling curative therapies
Read the article
Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need
We aim to overhaul biomedical innovation to match scientific progress through Adaptive Biomedical Innovation (ABI), integrating tools to accelerate reliable delivery of medical products addressing unmet needs, fostering stakeholder collaboration and adaptive decision-making to manage uncertainties effectively.
Read the article
Advancing Healthcare through Innovation and Collaboration
NEWDIGS fosters collaborative, innovative solutions to biomedical innovation challenges, exemplified by Evidera's involvement in LEAPS, aiming to create a purpose-driven evidence ecosystem integrating real-world and trial data for patient-centered innovation.
Read the article
BioCentury OpEd: Biomedical Innovation Requires Health System Innovation
Gigi Hirsch & Jane Barlow's BioCentury commentary sparks discussions on prioritizing the "Next Big Thing" at the Center for Biomedical System Design and NEWDIGS, emphasizing the shift from drug cost to health efficiency and inviting feedback to advance biomedical innovation.
Read the Op Ed
NEWDIGS Consortium Awarded Danaher Foundation Community Impact Grant
Our work in NEWDIGS aligns with the Danaher Foundation’s goal in healthcare innovation of improving the patient journey by accelerating accurate diagnosis, the development of, and access to innovative treatments for cancer and rare diseases.
Read the announcement
